Keymed Biosciences Inc. (2162.HK)

HKD 48.0

(7.5%)

Total Debt Summary of Keymed Biosciences Inc.

  • Keymed Biosciences Inc.'s latest annual total debt in 2023 was 418.7 Million CNY , up 243.29% from previous year.
  • Keymed Biosciences Inc.'s latest quarterly total debt in 2024 Q1 was 719.54 Million CNY , up 71.85% from previous quarter.
  • Keymed Biosciences Inc. reported annual total debt of 121.96 Million CNY in 2022, up 210.65% from previous year.
  • Keymed Biosciences Inc. reported annual total debt of 39.26 Million CNY in 2021, down -41.28% from previous year.
  • Keymed Biosciences Inc. reported quarterly total debt of 719.54 Million CNY for 2024 Q1, up 71.85% from previous quarter.
  • Keymed Biosciences Inc. reported quarterly total debt of 458.49 Million CNY for 2023 Q3, up 38.35% from previous quarter.

Annual Total Debt Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Total Debt of Keymed Biosciences Inc. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 418.7 Million CNY 243.29%
2022 121.96 Million CNY 210.65%
2021 39.26 Million CNY -41.28%
2020 66.86 Million CNY -12.54%
2019 76.44 Million CNY 0.0%

Peer Total Debt Comparison of Keymed Biosciences Inc.

Name Total Debt Total Debt Difference
Uni-Bio Science Group Limited 52.86 Million HKD -692.004%
CK Life Sciences Int'l., (Holdings) Inc. 5.93 Billion HKD 92.94%